Keywords: 5-HT; Serotonin; Ach; acetylcholine; AchE; acetylcholinesterase; AChR; acetylcholine receptor; BLA; basolateral amygdala; CEA; central amygdala; ChAT; choline acetyltransferase; CNS; central nervous system; DRG; dorsal root ganglion; EPSC; excitatory post
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Myasthenia gravis; Systemic lupus erythematosus; Acetylcholine receptor antibody; Antinuclear antibody; Antiphospholipid antibody; Thymectomy; AChR; Acetylcholine receptor; anti-AChR antibody; Anti-acetylcholine receptor antibody; ANA; Antinuclear antibod
Keywords: ACTH; adrenocorticotropic hormone; AChR; acetylcholine receptor; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Ca2+; a calcium ion; CA1; cornu ammonis area 1, a region in the hippocampus anatomy; CO2; car
Keywords: Abs; antibodies; AchR; muscle acetylcholine receptor; IVIg; intravenous immunoglobulin; MG; myasthenia gravis; MGFA-PIS; myasthenia gravis foundation of America-post interventional status; MGCS; myasthenia gravis composite scale; MuSK; muscle-specific tyr
Keywords: OMG; ocular myasthenia gravis; SP; seropositive; SN; seronegative; AChR; acetyl choline receptor; MuSK; muscle-specific kinase; RSEMG; repetitive stimulation electromyography; SFEMG; single-fiber electromyography;
Keywords: AchR; nicotinic acetylcholine receptor; aHR; adjusted hazard ratio; CI; confidence interval; COPD; chronic obstructive pulmonary disease; HR; hazard ratio; ICD-9-CM; The International Classification of Diseases, Ninth Revision, Clinical Modification; IL;
Keywords: AChR; acetylcholine receptor; ELISA; enzyme-linked immunosorbent assay; GMT; geomean titre; HC; healthy controls; IM; immunosuppressive medication; LEMS; Lambert-Eaton myasthenic syndrome; MG; myasthenia gravis; MG-ADL; MG specific Activities of Daily Liv
Keywords: Myasthenia gravis; Nicotinic acetylcholine receptor; Immunoadsorption; Therapy; Experimental autoimmune myasthenia gravis; MG; myasthenia gravis; EAMG; experimental autoimmune MG; AChR; nicotinic acetylcholine receptor; ECD; extracellular domain; MIR; mai
Keywords: MFGM; milk fat globule membrane; NMJ; neuromuscular junction; EDL; extensor digitorum longus; AChR; acetylcholine receptors; α-BTX; α-bungarotoxin; LRP4; LDL Receptor Related Protein 4; Aging; Exercise; Milk fat globule membrane; Motor function; Neuromu
Keywords: ABTSâ¢; 2,2â²-azinobis(3-ethylbenzthiazoline-6-sulfonic acid free radical; Ach; acetylcholine; AchR; acetylcholine receptor; AOPP; advanced oxidation protein products; FRAP; ferric reducing antioxidant potential; GMG; generalized myasthenia gravis; MG;
Keywords: AChR; acetylcholine receptor; AChR-EOMG; acetylcholine receptor-early onset AChR-MG; AZA; azathioprine; IPA; Ingenuity Pathway analysis; lincRNAs; long non-coding intergenic RNAs; lncRNAs; long non-coding RNAs; MG; myasthenia gravis; miRNAs; microRNAs; pr
Keywords: MG; myasthenia gravis; EBV; Epstein-Barr virus; TLR; Toll-like receptor; GC; germinal center; IFN; interferon; AChR; acetylcholine receptor; EBER; EBV-encoded small RNA; LCM; laser-capture microdissection; IRF8; interferon regulatory factor 8; LMP1; Eps
Keywords: BTX; bungarotoxin; CME; clathrin-mediated endocytosis; ER stress; endoplasmic reticulum stress; ERAD; endoplasmic reticulum-associated degradation; MβCD; methyl-beta-cyclodextrin; MFI; mean fluorescence intensity; AChR; acetylcholine receptor; ATF6; acti
Keywords: AChE; Acetylcholinesterase; AChR; Acetylcholine Receptor; ALG13,14; UDP-N-acetylglucosaminyltransferase subunit 13, 14; AMDHD2; Amidohydrolase domain containing 2; ATP; Adenosine triphosphate; Aβ; Amyloid β; CDG; Congenital disorders of glycosylation; C
Keywords: MG; myasthenia gravis; AChR; acetylcholine receptor; MuSK; muscle specific kinase; EAMG; experimentally acquired myasthenia gravis; PTMG; passive transfer myasthenia gravis; Myasthenia gravis; Clinical trials; Therapeutic development; Preclinical assessme
Keywords: MG; myasthenia gravis; AChR; nicotinic acetylcholine receptor; ECD; extracellular domain; MIR; main immunogenic region; AChBP; acetylcholine binding protein; α-Btx; α-bungarotoxin.; Nicotinic acetylcholine receptor; Extracellular domain; Myasthenia grav
Keywords: ACh; acetylcholine; AChE; acetylcholinesterase; AChR; acetylcholine receptors; agg; aggrecan; B2M; β2-microglobulin; BMP; bone morphogenetic protein; cAMP; cyclic adenosine monophosphate; cDNA; complementary desoxyribonucleic acid; CO2; carbon dioxide; D
Keywords: Neuromuscular junction; Doublecortin; Lissencephaly type I; Synapse formation; AChR; acetylcholine receptor; BTX; bungarotoxin; Cdk; cyclin-dependent kinase; Dcx; doublecortin; Dclk; doublecortin-like kinase; HSA; human skeletal actin; LRP4; low density l
Keywords: AChR; acetylcholine receptor; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; AMR; antibody-mediated rejection; ANCA; anti-neutrophil cytoplasmic antibody; AP; alternative pathway; C1-INH; C1 esterase inhibitor; C3GN; C3 g
Keywords: AChR; acetylcholine receptor; AChR-Ab; acetylcholine receptor antibody; AIRE; autoimmune regulator; APECED; autoimmune polyendocriopathy candidiasis ectodermal dystrophy; APS-I; autoimmune polyendocrine syndrome type-I; EOMG; early onset Myasthenia gravis
Keywords: SLRP; small leucine-rich proteoglycan; LRR; leucine-rich repeat; RTK; receptor tyrosine kinase; GAG; glycosaminoglycan; HS; heparan sulfate; HSPG; heparan sulfate proteoglycan; He; heparin; CS; chondroitin sulfate; KS; keratan sulfate; CSPG; chondroitin s
Keywords: ACh; acetylcholine; AChR; acetylcholine receptor; AZ; active zone; CaV; voltage-gated calcium channel; [Ca2+]i, [Ca2+]o; concentrations of Ca2+ inside and outside the motor nerve terminal; CNS; central nervous system; EPC; endplate current; EPP; endplate
Keywords: AchR; acethylcholine receptor; AP-1; activator protein 1; cAMP; cyclic adenosine monophosphate; cdc42; cell division control protein 42 homolog; cGMP; cyclic guanosine monophosphate; CNS; central nervous system; EF; electric filed; EGFR; epidermal growth
Keywords: α-BTX; α-bungarotoxin; AChR; acetylcholine receptor; BSA; bovine serum albumin; DABCO; 1,4-diazabicyclo[2.2.2]octane; FDB; flexor digitorum brevis; FDL; flexor digitorum longus; NMJ; neuromuscular junction; PFA; paraformaldehyde; Lower motor neuron; Lum
Keywords: A1AR; adenosine A1 receptor; A2AAR; adenosine A2A receptor; A2BAR; adenosine A2B receptor; A3AR; adenosine A3 receptor; MG; myasthenia gravis; EAMG; experimental autoimmune myasthenia gravis; AChR; acetylcholine receptor; AChR R97-116; rat AChR α97-116 p
Keywords: CVF; cobra venom factor; rCVF; recombinant CVF; hCVF; humanized CVF; MAC; membrane attack complex; PNH; paroxysmal nocturnal hemoglobinuria; MI/RI; myocardial ischemia reperfusion injury; GI/RI; gastrointestinal ischemia reperfusion injury; AMD; age-relat
Keywords: AcCoA; acetyl-coenzyme A; ACh; acetylcholine; AChE; acetylcholinesterase; AChR; ACh receptors; AD; Alzheimer's disease; ANS; autonomic nervous system; AThCh; acetylthiocholine; BAPTA-AM; 1,2-bis-(2-aminophenoxy)ethane N,N,N,Nâ²-tetraaceticacid tetra(ac
Keywords: Nicotine; Perceptual learning; Acetylcholine; Memory consolidation; Alpha; P300; ACh; acetylcholine; AChR; ACh receptor; C-group; control group; EEG; electroencephalography; ERP; event-related potential; FFT; fast Fourier transformation; nAChR; nicotinic
Keywords: 3D; three-dimensional; AchR; acetylcholine receptor; ASA; water-accessible surface area; BP; blood pressure; CHGA; chromogranin A; CST; catestatin; DBP; diastolic blood pressure; DSI; Data Sciences International (St. Paul, MN); HR; heart rate; NMR; nuclea
Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis
Keywords: Abs; antibodies; ACh; acetylcholine; AChR; ACh receptors; ALS; amyotrophic lateral sclerosis; auto-Abs; auto-antibodies; CMAPs; compound muscle action potentials; EAMG; experimental autoimmune MG; ECD; extracellular domain; ENU; N-ethyl-N-nitrosourea; Ig;
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
Keywords: Glucagon-like peptide-1; Glucose metabolism; Vagus nerve; Liraglutide; Brain stem; Pancreatic β-cell proliferation; AP; Area postrema; ARC; Arcuate nucleus; AChR; Acetylcholine receptor; α-MSH; Alpha-melanocyte-stimulating hormone; BBB; Blood brain barr
Endogenous acetylcholine regulates neuronal and astrocytic vascular endothelial growth factor expression levels via different acetylcholine receptor mechanisms
Keywords: Vascular endothelial growth factor; Endogenous acetylcholine; Acetylcholine receptor; Medial septal cholinergic neurons; ACh; acetylcholine; AChE; acetylcholinesterase; AChR; acetylcholine receptor; AraC; cytosine β-d-arabinofuranoside hydrochloride; CCh
Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice
Keywords: AChR; acetylcholine receptor; BTX; bungarotoxin; CFA; complete Freund's adjuvant; DMEM; Dulbecco's Modified Eagle Medium; EAMG; experimental autoimmune MG; ELISA; enzyme-linked immunosorbent assay; FBS; fetal bovine serum; IFA; incomplete Freund's a
Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues
Keywords: AChR; acetylcholine receptor; DGCR8; DiGeorge syndrome Critical Region gene 8; FC; fold change; FMR1; fragile X mental retardation 1; IFN-I/β; type-I interferon/interferon β; IFNAR; interferon alpha and beta receptor subunit; MG; Myasthenia Gravis; miRN
Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms
Keywords: AChR; nicotinic acetylcholine receptor; ACh; acetylcholine; TCAs; tricyclic antidepressants; α-BTx; α-bungarotoxin; MLA; methyllycaconitine; RT; room temperature; IC50; ligand concentration that produces 50% inhibition (of binding or of agonist activati
Pharmacological characterization of histamine-gated chloride channels from the housefly Musca domestica
Keywords: ACh; acetylcholine; AChR; ACh receptor; Am; amthamine; Cho; choline; DA; dopamine; GABA; γ-aminobutyric acid; GABACl; GABA-gated chloride channel; GABAR; GABA receptor; Glu; l-glutamate; GluCl; Glu-gated chloride channel; HA; histamine; HACl; HA-gated ch
Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains
Keywords: MG; myasthenia gravis; AChR; nicotinic acetylcholine receptor; ECD; extracellular domain; MIR; main immunogenic region; AChBP; acetylcholine binding protein; α-Btx; α-bungarotoxin; EAMG; experimental autoimmune myasthenia gravis; EMG; electromyography;
Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons
Keywords: μOR; mu opioid receptor; ACh; acetylcholine; AChR; acetylcholine receptor; ChAT; choline acetyltransferase; CPP; conditioned place preference; DA; dopamine; DREADD; designer receptors exclusively activated by designer drugs; GABA; gamma-aminobutyric acid
Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease
Keywords: ACh; acetylcholine; AChR; acetylcholine receptor; AD; Alzheimer's disease; APP; amyloid precursor protein; Aβ; amyloid beta; ChAT; choline acetyltransferase; GCL; ganglion cell layer; GFAP; glial fibrillary acidic protein; IHC; immunohistochemistry; iI
Pharmacological targeting of allergen-specific T lymphocytes
Keywords: 6-MP; 6-mercaptopurine; AP-1; activator protein 1; AChR; acetylcholine receptor; AIT; Allergen-specific immunotherapy; ARA; adrenergic receptor agonist; AR; adrenergic receptor; APL; altered peptide ligands; AICART; aminoimidazole carboxamide ribonucleoti
Cullin E3 Ligase Activity Is Required for Myoblast Differentiation
Keywords: UPS; ubiquitin-proteasome system; CRL; Cullin-RING (really interesting new gene) ligase; NAE1; NEDD8 activating enzyme E1 subunit 1; MyHC; myosin heavy chain; siRNA; small interfering RNA; NMJ; neuromuscular junction; AChR; acetylcholine receptor; BTB;
High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model
Keywords: Autoimmunity; BAFF receptor (BR); EAMG; AChR; mAb-siRNA; Fas;
Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula
Keywords: AChR; nicotinic acetylcholine receptor; ACh; acetylcholine; NCA; noncompetitive antagonist; RT; room temperature; MHb; medial habenula; VI; ventral inferior; Ki; inhibition constant; Kd; dissociation constant; IC50; ligand concentration that produces 50%
Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis
Keywords: AChR; Acetylcholine receptor; GAPDH; Glyceraldehyde 3-phosphate dehydrogenase; MG; Myasthenia gravis; MG-ADL; MG-specific activities of daily living scale; MuSK; Muscle-specific receptor tyrosine kinase; qRT-PCR; Quantitative reverse transcription-polymer
Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity
Keywords: AChR; Acetylcholine receptor; DSS; Disease severity score; MuSK-Ig1; MuSK Ig-like 1 domain; Fz-like domain; Frizzled-like domain; LEMS Lambert-Eaton; Myasthenic syndrome; Lrp4; Low-density lipoprotein receptor-related protein 4; MIR; Main immunogenic regi
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
Keywords: AChR; acetylcholine receptor; AdR; adrenergic receptors; ANA; anti-nuclear antibodies; CFS; Chronic Fatigue Syndrome; GPCR; G-protein coupled receptor; POTS; Postural Orthostatic Tachycardia Syndrome; RRTI; Recurrent respiratory tract infections; TG; thyr
Impaired regulatory B cells in myasthenia gravis
Keywords: MG; myasthenia gravis; Bregs; regulatory B cells; AChR; acetylcholine receptor; GM-CSF; granulocyte-macrophage colony-stimulating factor; IL-10; interleukin-10; IFN-γ; interferon-γ; TNF-α; tumor necrosis factor-α; TGF-β; transforming growth factor-β
Research PaperMyf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis
Keywords: AChR; Acetylcholine receptor; AIRE; Autoimmune regulator; EOMG; Early onset myasthenia gravis; LOMG; Late onset myasthenia gravis; LRP4; Low-density lipoprotein receptor-related protein 4; MG; Myasthenia gravis; MHC; Major histocompatibility complex; MuSK
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors
Keywords: Human α4β2 nicotinic acetylcholine receptor; Bupropion; (±)-SADU-3-72; Molecular docking; Luminal and non-luminal sites; Ca2+ influx; AChR; nicotinic acetylcholine receptor; NCA; noncompetitive antagonist; (±)-BP; (±)-bupropion [(±)-2-(tert-butylami
Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content
Keywords: 5-HT; 5-hydroxytryptamine (serotonin); m5-HT3AR; murine serotonin type 3A receptor; AChR; nicotinic acetylcholine receptor; ACh; acetylcholine; NMDAR; N-methyl-D-aspartate receptor; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NI